2024-09-21 - Analysis Report
## HCA Healthcare Inc (HCA) Stock Analysis Report

**Company Overview:** HCA Healthcare Inc. is a leading provider of healthcare services in the United States, operating a network of hospitals and other healthcare facilities. 

**Performance Analysis:**

1. **Performance vs. S&P 500 (VOO):** 
    * HCA's cumulative return is **329.07%**, significantly outperforming the S&P 500's return of **133.16%**. 
    * The relative divergence of **195.91** indicates a significant outperformance compared to the S&P 500, placing it at the 96.76th percentile of its historical range.

2. **Recent Price Movement:**
    * **Closing Price:** $399.8
    * **5-Day Moving Average:** $399.43
    * **20-Day Moving Average:** $392.69
    * **60-Day Moving Average:** $360.07 
    * The stock is trading slightly above its short-term moving averages, suggesting potential for continued upward momentum. However, the longer-term averages are further below, indicating possible consolidation or downward pressure.

3. **Technical Indicators:**
    * **RSI:** 57.96 - This indicates a moderately overbought condition, suggesting potential for a short-term pullback.
    * **PPO:** -0.19 - This indicates a slightly bearish signal, suggesting potential for a decline.
    * **Delta_Previous_Relative_Divergence:** -2.54 - This indicates a recent short-term decline in the relative strength of HCA compared to the market. 
    * **Expected_Return:** 6.59% -  This represents the potential annualized return over a 5-10 year investment horizon.

4. **Recent Earnings and Outlook:**

| Date       | EPS    | Revenue     |
| ---------- | ------ | ----------- |
| 2024-07-29 | 5.6   | $17.49B    |
| 2024-05-02 | 6.01  | $17.34B    |
| 2023-10-26 | 3.98  | $16.21B    |
| 2023-08-02 | 4.35  | $15.86B    |

* **Most Recent Earnings (2024-07-29):** The EPS of $5.6 exceeded analyst expectations, suggesting strong performance. Revenue also exceeded expectations, indicating continued growth.

**Overall Analysis:**

HCA Healthcare Inc. continues to demonstrate strong performance with impressive returns exceeding the S&P 500. Recent earnings have exceeded expectations, indicating robust financial health and growth potential. While technical indicators suggest possible near-term volatility, the stock remains attractive for long-term investors seeking exposure to the healthcare sector. However, potential investors should consider the moderately overbought condition indicated by the RSI and the slight bearish signal from the PPO. The expected return of 6.59% provides a positive outlook for future growth. 
